Skip to main content

Making a Sale

Shares of this name are holding steady after mixed news, making this a good time take some profits. Also, updating another holding.
  • Author:
  • Publish date:
Comments

Model portfolio holding Parexel (PRXL) gave mixed messages during its presentation at the Goldman Healthcare conference late Tuesday. The medical contract research organization (CRO) said that requests for proposals were running ahead of the prior quarter's pace, offset by competitive industry pricing.

The question, then, is what to do now that the stock is holding up well in a down market today, recently changing hands around $13.30. In fact, the stock is up for the 11 of the past 12 sessions, and at the current level is now 52% above its average cost basis in the model portfolio.

With that in mind, and keeping in line with commentary from Friday's Weekly Summary, we're going to sell 100 shares of Parexel after you read this Alert. This trade leaves 300 shares, or 3.75% of the overall portfolio.

Turning to another name, Imax (IMAX) , as expected, started to put its recent $70 million equity offering to work overnight. The company announced the repurchase of $44.3 million of 9.625% notes, set to mature in December 2010. The company paid 97.75 cents on the dollar.

Imax shares are down fractionally on the session, and remain attractive to hold at the recent price of $7.18.

*****************************************************

Have you had an opportunity to trade alongside Jim Cramer? Every day more stocks are being beaten down by Wall Street estimates. Now's the time to act on Cramer's recommendations. Get started for free today.

http://secure2.thestreet.com/cap/prm.do?OID=012750

*****************************************************

TheStreet.com is a publisher and a registered investment adviser. TheStreet.com Stocks Under $10 contains the authors' own opinions, and none of the information contained therein constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You further understand that the Stocks Under $10 Investment Team will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in TheStreet.com Stocks Under $10 may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

Past results are not necessarily indicative of future performance. Investing in the stocks chosen forTheStreet.com Stocks Under $10 model portfolio is riskyand speculative. The companies may have limited operatinghistories and little available public information, and thestocks they issue may be volatile and illiquid. Trading insuch securities can result in immediate and substantial losses of the capital invested. You should use only risk capital, and not capital required for other purposes, such as retirement savings, student loans, mortgages or education. As an editorial employee of TheStreet.com, Peltier is restricted from owning individual securities other than stock or options in TheStreet.com, Inc.

*****************************************************

(c) 2009 TheStreet.com, Inc., 14 Wall Street, 15th Floor,New York, NY 10005, Attention: Customer Service Department